View Cart (0 items)

Carlyle Group enters talks to acquire Pharmaceutical Product Development Inc.

August 16, 2011
/ Print / Reprints /
| Share More
/ Text Size+

NEW YORK — The Carlyle Group, a global asset management firm, is in talks to acquire contract drug developer Pharmaceutical Product Development Inc. (PPD), Bloomberg reported.

Carlyle has edged out several other private-equity firms and entered into exclusive talks with the Wilmington, N.C.-based drug maker, the article stated.

PPD, which has a market cap of $3.5 billion, provides contract drug development and discovery services for pharmaceutical, biotechnology, medical device, academic and government organizations.
You must login or register in order to post a comment.

Related Products